Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.06
-0.01 (-0.48%)
At close: Aug 15, 2025, 3:59 PM
2.05
-0.24%
After-hours: Aug 15, 2025, 07:46 PM EDT
Esperion Therapeutics Revenue
Esperion Therapeutics reported an annual revenue of $332.31M, reflecting a 185.66% growth. For the quarter ending June 30, 2025, Esperion Therapeutics generated $82.39M in revenue.
Revenue (ttm)
332.31M
Revenue Growth
185.66%
Price / Sales Ratio
1.24
Revenue / Employee
1.09M
Employees
304
Market Cap
407.3M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|